Log in to save to my catalogue

Relief, NeuroRx End Litigation; NeuroRx Transfers To Relief Formulation Of Aviptadil Product

Relief, NeuroRx End Litigation; NeuroRx Transfers To Relief Formulation Of Aviptadil Product

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2756683469

Relief, NeuroRx End Litigation; NeuroRx Transfers To Relief Formulation Of Aviptadil Product

About this item

Full title

Relief, NeuroRx End Litigation; NeuroRx Transfers To Relief Formulation Of Aviptadil Product

Publisher

Miami: ContentEngine LLC, a Florida limited liability company

Journal title

CE Noticias Financieras, 2022

Language

English

Publication information

Publisher

Miami: ContentEngine LLC, a Florida limited liability company

More information

Alternative Titles

Full title

Relief, NeuroRx End Litigation; NeuroRx Transfers To Relief Formulation Of Aviptadil Product

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_2756683469

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2756683469

How to access this item